Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

“Jumping too far ahead”: Australian healthcare professional, scientist, and policy maker perspectives on using genomics in newborn screening

14 Oct 2025

Abstract excerpt

The future use of genomics in Australia's newborn bloodspot screening (NBS) program is likely to be associated with both positive and negative impacts. Before adopting this technology, it is important to understand the views of all stakeholders, including scientists, health care professionals (HCPs) and policy-makers involved in delivering the program. Semi-structured interviews or small group discussions were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ethics in Clinical Research
Share to Genomics and Rare Diseases
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 41087733
DOI: 10.1038/s41431-025-01954-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

“Jumping too far ahead”: Australian healthcare professional, scientist, and policy maker perspectives on using genomics in newborn screeningPMID 41087733Read ↗

Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screeningSemantic proximity Read ↗

Genetic newborn screening stakeholder perspectivesSemantic proximity Read ↗

Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?Semantic proximity Read ↗

Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in AustraliaSemantic proximity Read ↗

Exploring the feasibility, acceptability and impact of genomic newborn screening for rare diseases in England: A study protocol for the Generation Study - Process and Impact Evaluation (Version 2)Semantic proximity Read ↗

Newborn Screening by Genomic Sequencing: Opportunities and ChallengesSemantic proximity Read ↗

Genomic sequencing for newborn screening: current perspectives and challengesSemantic proximity Read ↗

Ethical issues raised by new genomic technologies: the case study of newborn genome screeningSemantic proximity Read ↗

Australians’ views and experience of personal genomic testing: survey findings from the Genioz studySemantic proximity Read ↗

Genomic newborn screening: feasibility, acceptability and clinical outcomesSemantic proximity Read ↗

The Future of Newborn Genomic ScreeningSemantic proximity Read ↗

From newborn screening to genomic medicine: challenges and suggestions on how to incorporate genomic newborn screening in public health programsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.